RGLS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Regulus Therapeutics (RGLS) Earnings Date & Reports

Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

RGLS is expected to report earnings to rise 22.75% to -24 cents per share on May 08

Regulus Therapeutics RGLS Stock Earnings Reports

Q1'25

Est.

$-0.25

Q4'24

Missed

by $0.03

Q3'24

Missed

by $0.04

Q2'24

Missed

by $0.05

Q1'24

Missed

by $0.07

The last earnings report on March 13 showed earnings per share of -20 cents, missing the estimate of -17 cents. With 1.25M shares outstanding, the current market capitalization sits at 153.68M.

View a ticker or compare two or three

Compare

RGLS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For RGLS
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Other

Address

4224 Campus Point Court

Phone

+1 858 202-6300

Employees

Web

https://www.regulusrx.com